BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8156531)

  • 21. Clinical relevance of DNA ploidy and proliferative activity in childhood rhabdomyosarcoma: a retrospective analysis of patients enrolled onto the Italian Cooperative Rhabdomyosarcoma Study RMS88.
    De Zen L; Sommaggio A; d'Amore ES; Masiero L; di Montezemolo LC; Linari A; Madon E; Dominici C; Bosco S; Bisogno G; Carli M; Ninfo V; Basso G
    J Clin Oncol; 1997 Mar; 15(3):1198-205. PubMed ID: 9060564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma.
    Ganti R; Skapek SX; Zhang J; Fuller CE; Wu J; Billups CA; Breitfeld PP; Dalton JD; Meyer WH; Khoury JD
    Mod Pathol; 2006 Sep; 19(9):1213-20. PubMed ID: 16729016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of invasion promoting genes in childhood rhabdomyosarcoma.
    Armeanu-Ebinger S; Bonin M; Häbig K; Poremba C; Koscielniak E; Godzinski J; Warmann SW; Fuchs J; Seitz G
    Int J Oncol; 2011 Apr; 38(4):993-1000. PubMed ID: 21271214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid variant of alveolar rhabdomyosarcoma with unbalanced t(2;13) and hypotetraploidy, without MYCN amplification.
    Smith A; Sharma P; Tomlinson J; Robson L; Goldrick A
    Pathology; 2001 Feb; 33(1):108-11. PubMed ID: 11280599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children's Oncology Group.
    Rodeberg DA; Garcia-Henriquez N; Lyden ER; Davicioni E; Parham DM; Skapek SX; Hayes-Jordan AA; Donaldson SS; Brown KL; Triche TJ; Meyer WH; Hawkins DS
    J Clin Oncol; 2011 Apr; 29(10):1304-11. PubMed ID: 21357792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.
    Kohashi K; Oda Y; Yamamoto H; Tamiya S; Takahira T; Takahashi Y; Tajiri T; Taguchi T; Suita S; Tsuneyoshi M
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1097-103. PubMed ID: 18386058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
    Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
    Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.
    Fernandez K; Serinagaoglu Y; Hammond S; Martin LT; Martin PT
    Am J Pathol; 2010 Jan; 176(1):416-34. PubMed ID: 20019182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes on chromosome 11p15.5 as specific marker for embryonal rhabdomyosarcoma?
    Vicha A; Jencova P; Novakova-Kodetova D; Stolova L; Voriskova D; Vyletalova K; Broz P; Drahokoupilova E; Guha A; Kopecká M; Krskova L
    Genes Chromosomes Cancer; 2023 Dec; 62(12):732-739. PubMed ID: 37530573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
    Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
    J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Strategy for Pediatric Paratesticular Rhabdomyosarcoma Based on Chimeric Gene Assessment.
    Unno R; Mizuno K; Ito Y; Etani T; Okada A; Kawai N; Yasui T; Saitoh S; Hayashi Y
    Urology; 2016 Sep; 95():187-9. PubMed ID: 27017905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orbital rhabdomyosarcoma: relationship between DNA ploidy, p53, bcl-2, MDR-1 and Ki67 (MIB1) expression and clinical behavior.
    Staibano S; Franco R; Tranfa F; Mezza E; Lo Muzio L; Strianese D; Errico ME; Bufo P; Ferrara G; Somma P; Mansueto G; Greco I; Fiorillo A; Bonavolontà G; De Rosa G
    Anticancer Res; 2004; 24(1):249-57. PubMed ID: 15015604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of FOXO1 break-apart status by fluorescence in situ hybridization in atypical alveolar rhabdomyosarcoma.
    Fu L; Jin Y; Jia C; Zhang J; Tai J; Li H; Chen F; Shi J; Guo Y; Ni X; He L
    Sci China Life Sci; 2017 Jul; 60(7):721-728. PubMed ID: 28646473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma.
    Seki M; Nishimura R; Yoshida K; Shimamura T; Shiraishi Y; Sato Y; Kato M; Chiba K; Tanaka H; Hoshino N; Nagae G; Shiozawa Y; Okuno Y; Hosoi H; Tanaka Y; Okita H; Miyachi M; Souzaki R; Taguchi T; Koh K; Hanada R; Kato K; Nomura Y; Akiyama M; Oka A; Igarashi T; Miyano S; Aburatani H; Hayashi Y; Ogawa S; Takita J
    Nat Commun; 2015 Jul; 6():7557. PubMed ID: 26138366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma: A potential treatment target in rare cases?
    Mitra S; Sydow S; Magnusson L; Piccinelli P; Törnudd L; Øra I; Ljungman G; Sandgren J; Gisselsson D; Mertens F
    Genes Chromosomes Cancer; 2022 Jan; 61(1):5-9. PubMed ID: 34418214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The expression of WT1 in the differentiation of rhabdomyosarcoma from other pediatric small round blue cell tumors.
    Carpentieri DF; Nichols K; Chou PM; Matthews M; Pawel B; Huff D
    Mod Pathol; 2002 Oct; 15(10):1080-6. PubMed ID: 12379755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Updates on comparative genomic hybridization study in rhabdomyosarcoma].
    Li DL; Liu CX; Zou H; Li F
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):420-3. PubMed ID: 21914357
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evidence of genetic alterations in chromosome 11 in embryonal and alveolar rhabdomyosarcoma].
    Brinkschmidt C; Poremba C; Schäfer KL; Simon R; Jürgens H; Böcker W; Dockhorn-Dworniczak B
    Verh Dtsch Ges Pathol; 1998; 82():210-4. PubMed ID: 10095436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediatric embryonal and alveolar rhabdomyosarcomas.
    Mahoney SE; Yao Z; Keyes CC; Tapscott SJ; Diede SJ
    Epigenetics; 2012 Apr; 7(4):400-8. PubMed ID: 22419069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
    Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.